- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Glenmark Pharma launches generic Lacosamide injection in US | 2 | capitalmarket.com | ||
| 02.06. | Klage gegen Glenmark: Lieferengpässe: Kein Schadenersatz für DAK | 4 | APOTHEKE ADHOC | ||
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 01.06. | Stocks to Watch Today (June 01, 2026): IndiGo, Glenmark Pharma, IREDA, NMDC, Jubilant Pharmova, Cyient and more | 2 | ZEE Business | ||
| 01.06. | Stock Alert: RPP Infra Projects, Indigo, NMDC, GRM Overseas, Glenmark Pharma, NOCIL | 2 | capitalmarket.com | ||
| 30.05. | Glenmark Pharma posts robust Q4 performance | 3 | capitalmarket.com | ||
| 20.05. | IGI, Inc.: Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors | 347 | GlobeNewswire (Europe) | Next-generation multispecific antibody, ISB 2301, targets 3 tumor-associated antigens (TAAs) and activates both T cells and natural killer (NK) cells
IGI's clinically validated BEAT platform enabled... ► Artikel lesen | |
| 18.05. | Glenmark Launches Vancomycin Injection In US, Targets Rs 37.9 Million Market | 2 | The Free Press Journal | ||
| 12.05. | Glenmark Pharmaceuticals Ltd slips for fifth straight session | 2 | capitalmarket.com | ||
| 23.04. | Glenmark Pharmaceuticals Ltd spurts 3.28% | 2 | capitalmarket.com | ||
| 09.04. | Glenmark Gets FDA Approval for Bioequivalent Progesterone Vaginal Insert | 6 | Contract Pharma | ||
| 09.04. | Glenmark Pharmaceuticals Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 mg | 910 | PR Newswire | ELMWOOD PARK, N.J., April 9, 2026 /PRNewswire/ -- Glenmark Pharmaceuticals Limited (Glenmark) has received final approval from the United States Food & Drug Administration... ► Artikel lesen | |
| 09.04. | Glenmark Pharma gets USFDA nod for Progesterone Vaginal Inserts | 5 | capitalmarket.com | ||
| 02.04. | Glenmark goes direct with new US Ryaltris marketing plan as it drops partner model | 5 | FiercePharma | ||
| 01.04. | Glenmark Pharmaceuticals Announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS in the U.S., Significantly Expanding Its Innovative Portfolio | 180 | PR Newswire | RYALTRIS® is Glenmark's first innovative product introduced into the U.S. market
ELMWOOD PARK, N.J., April 1, 2026 /PRNewswire/ -- Glenmark Pharmaceuticals Inc.... ► Artikel lesen | |
| 31.03. | Glenmark Pharmaceuticals Canada Inc. Launches Men's GLN-Minoxidil 5% w/w Topical Aerosol Foam in Canadian Retail | 385 | PR Newswire | GLN-Minoxidil Men's 5% Foam is a topical treatment formulated with 5% minoxidil, a widely used and clinically established ingredient for supporting hair regrowth in men. The fast-drying, unscented aerosol... ► Artikel lesen | |
| 24.03. | Glenmark Pharma may outperform amid market correction; technicals turn positive: Ruchit Jain | 4 | Times of India | ||
| 21.03. | Glenmark Pharma launches GLIPIQ (semaglutide) in India for Type 2 Diabetes at lower cost | 3 | capitalmarket.com | ||
| 19.03. | Glenmark secures USFDA nod for OTC Nasal Spray; launches Generic Milnacipran tablets in US | 3 | capitalmarket.com | ||
| 16.03. | Glenmark Pharma gains as US arm to launch Potassium Phosphates Injection | 2 | capitalmarket.com | ||
| 05.03. | FDA gives Glenmark thumbs up for first 'true' generic version of GSK's asthma inhaler Flovent | 4 | FiercePharma |
1 2 Weiter >>
36 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 1,855 | -2,88 % | Reed Sinopharm Exhibitions (RSE): PCHi 2026: World's Largest Cosmetics Ingredients Exhibition Opens in Hangzhou | 860+ exhibitors from 26 countries and regions across 70,000 sqmClose to 50 new product launches, including global and China debuts295 product submissions and 19 engineer nominations for the... ► Artikel lesen | |
| CSPC PHARMA | 0,770 | -2,96 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - SEMAGLUTIDE LONG-ACTING INJECTION (SYH9017) OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S. | ||
| WUXI BIOLOGICS | 3,275 | -2,96 % | WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility | SINGAPORE, June 4, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has completed... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 1,780 | +1,57 % | Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution | SHANGHAI, April 28, 2026 /PRNewswire/ -- On 28 April, Fosun Pharma ("the Company", stock code: 600196.SH; 02196.HK) announced its results for the first quarter... ► Artikel lesen | |
| GEDEON RICHTER | 33,840 | +0,30 % | Dividendenbekanntmachungen (03.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGEAS SA/NV BE0974264930 - 2,25 EUR AMKOR TECHNOLOGY INC US0316521006 0,0835 USD 0,0717 EUR AVERY DENNISON CORP US0536111091 1... ► Artikel lesen | |
| DR REDDYS | 11,300 | 0,00 % | DR REDDYS LABORATORIES LTD - 6-K, Report of foreign issuer | ||
| ASPEN PHARMACARE | 7,500 | 0,00 % | ASPEN PHARMACARE HOLDINGS LIMITED - Completion of the divestment of Aspen APAC | ||
| SHANGHAI PHARMACEUTICALS | 1,340 | 0,00 % | SH PHARMA (02607): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025 (UPDATED) | ||
| LUYE PHARMA | 0,204 | +5,70 % | LUYE PHARMA (02186): OVERSEAS REGULATORY ANNOUNCEMENT | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,099 | +1,02 % | SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO THE SHARE AWARD SCHEME | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,535 | 0,00 % | CHINARES PHARMA (03320): INSIDE INFORMATION REGISTRATION OF MEDIUM TERM NOTES BY THE NATIONAL ASSOCIATION OF FINANCIAL MARKET INSTITUTIONAL INVESTORS | ||
| HANSOH PHARMACEUTICAL | 3,219 | +1,51 % | CMSI: Three Reasons for Recent Underperformance of Pharma Sector vs HSI; Top Picks INNOVENT BIO , HANSOH PHARMA and KEYMED BIO-B | ||
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 0,905 | -2,69 % | SHINEWAY PHARM (02877): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 28 MAY 2026 | ||
| KALBE FARMA | 0,025 | -10,91 % | Dividendenbekanntmachungen (04.06.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A-LIVING SMART CITY SERVICES CO LTD CNE100002RY5 0,0688 HKD 0,0075 EUR ADESSO SE DE000A0Z23Q5 - 0,78 EUR AGEAS SA/NV ADR US00844W2089 2... ► Artikel lesen | |
| MERCK KGAA | 137,45 | 0,00 % | EQS-PVR: Merck KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Merck KGaA
Merck KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
08.06.2026 / 16:57 CET/CEST
Veröffentlichung... ► Artikel lesen |
GLENMARK PHARMACEUTICALS LTD gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLENMARK PHARMACEUTICALS LTD finden Sie auf Wallstreet Online.